Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

This study is not yet open for participant recruitment.
Verified December 2013 by Baker IDI Heart and Diabetes Institute
Sponsor:
Collaborators:
Servier Laboratories (Australia) Pty Ltd
Alfred and Baker Medical Unit - Alfred Hospital
Monash Medical Centre - Monash Health
Information provided by (Responsible Party):
Baker IDI Heart and Diabetes Institute
ClinicalTrials.gov Identifier:
NCT01483053
First received: November 27, 2011
Last updated: December 16, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)